Ozempic (Semaglutide)
Save up to 70%
Available Options
2mg/3mL
1 pre-filled pen (0.25mg or 0.5mg per dose)
4mg/3mL
1 pre-filled pen (1mg per dose)
Important Information
- • A valid prescription is required for all orders
- • Orders are shipped within 3–7 business days
- • Express shipping with cold chain packaging to keep your medication safe and effective
Description
Ozempic (semaglutide) is a prescription medication classified as a GLP-1 receptor agonist. It is specifically indicated for adults with Type 2 diabetes to effectively manage blood sugar levels in conjunction with diet and exercise. Ozempic offers unique therapeutic benefits, notably through a three-pronged mechanism: enhancing insulin secretion from the pancreas in response to meals, suppressing excessive glucagon secretion from the liver, and significantly slowing gastric emptying to improve post-meal blood sugar management.
The medication mimics the action of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone in the body. Ozempic is usually recommended when initial diabetic treatments, including lifestyle modifications and other medications, have not provided adequate glycemic control. It may also support modest weight reduction, making it beneficial for Type 2 diabetes patients who are overweight or obese.
Fact Table
| Formula | C187H291N45O59 |
|---|---|
| License | EU EMA, US FDA |
| Chemical Name | Semaglutide |
| Dosage (Strength) |
|
| Route | Subcutaneous injection |
| Bioavailability | 89% |
Directions
- Administer once weekly on the same day, at any time, with or without food.
- Begin with the lowest dose and titrate up per your healthcare provider’s instruction.
- Rotate injection sites (thigh, abdomen, upper arm) to minimize irritation.
Ingredients
The active ingredient is Semaglutide, specifically formulated for subcutaneous administration.
Cautions
- Contraindicated if you or a family member have medullary thyroid carcinoma (MTC) or MEN 2.
- Avoid if allergic to semaglutide or any excipients.
- Monitor for pancreatitis, renal issues, or retinopathy—seek care if symptoms arise.
- Refrigerate pens at 36–46°F (2–8°C) until first use; then either refrigerate or store at 59–86°F (15–30°C) for up to 56 days. Protect from light.
Interactions
May delay gastric emptying and alter absorption of oral drugs. Always tell your provider about all meds, supplements or herbs before starting Ozempic.
Side Effects
- Common: nausea, vomiting, diarrhea, abdominal discomfort, constipation, decreased appetite.
- Rare but serious: pancreatitis, kidney impairment, potential thyroid tumors. Seek immediate care for severe symptoms.
Frequently Asked Questions
What is Ozempic?
Ozempic (semaglutide) is a weekly injectable GLP-1 receptor agonist used alongside diet and exercise to improve blood sugar control in adults with Type 2 diabetes.
What is the difference between Ozempic and Rybelsus?
Both contain semaglutide; Ozempic is injected once weekly via pen, whereas Rybelsus is taken once daily by mouth.
Is Ozempic the same as Wegovy?
They share semaglutide but differ in indication and dose: Ozempic for Type 2 diabetes, Wegovy for chronic weight management at higher doses.
Is Ozempic (Semaglutide) safe?
Clinical trials show a favorable safety profile; animal studies raise a theoretical thyroid risk, but human relevance is uncertain. Always consult your doctor if you have thyroid concerns.
How much weight can you lose with Ozempic?
Patients often lose 10–14 lbs (4.5–6.3 kg) on higher doses due to appetite suppression and delayed gastric emptying.
Does Ozempic work immediately?
Blood sugar begins to drop soon after the first dose, but optimal control usually takes 4–5 weeks of consistent use.
What are the side effects of Ozempic?
Common: nausea, vomiting, diarrhea, abdominal discomfort, constipation. Rare but serious: pancreatitis, kidney issues, potential thyroid tumors—seek medical help if severe.
Is Ozempic available internationally?
Yes—approved and marketed in the US, EU, Canada, and many other regions worldwide.
Which is safer: Ozempic or Rybelsus?
Ozempic carries an FDA indication to reduce cardiovascular risk in diabetics, a benefit not formally approved for Rybelsus.
Important Note
The information above is provided for educational purposes only and should not replace professional medical advice. Please consult a qualified healthcare provider for personalized guidance on medication safety, suitability, and proper use.